April 26, 2024 2024 SARC Semiannual Meeting before ASCO is May 31, 2024 The 2024 SARC Semiannual Meeting before ASCO (all are welcome, no cost to attend) will take place on Friday, May 31, 2024 (8 am-12 pm CST) at the Hyatt Centric Chicago Magnificent Mile. Click to learn more about the agenda and to register. Read more
June 22, 2017 SARC-SUPPORTED RESEARCH SHOWS PEMBROLIZUMAB A POTENTIALLY VIABLE TREATMENT FOR A SUBSET OF SARCOMAS SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to report promising clinical trial results presented recently at ASCO 2017, the Annual Meeting of sarcoma cancer researchers. Melissa A. Burgess, … Read more
July 21, 2016 SARC RESEARCHERS REPORT IMMUNOTHERAPY EFFECTIVE IN SELECTED SARCOMA SUBTYPES PRELIMINARY RESULTS OF SARC028 In this first investigator-led study of pembrolizumab in multiple subtypes of sarcoma, researchers reported encouraging results at the recent ASCO (American Society of Clinical Oncology) meeting. … Read more